(May 24, 2017, 2:18 PM EDT) -- CHICAGO — In the wake of the raising of statute of limitations/statute of repose defenses at the 11th-hour of the first bellwether case, the Illinois federal judge overseeing the testosterone replacement therapy multidistrict litigation on May 23 ordered non-AbbVie Inc. defendants to replead any affirmative defenses that they contend still apply to a bellwether case (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, N.D. Ill., Eastern Div.)....